...
首页> 外文期刊>Chinese Medical Journal >Stereotactic radiosurgery in the treatment of primary central nervous system lymphoma
【24h】

Stereotactic radiosurgery in the treatment of primary central nervous system lymphoma

机译:立体定向放射外科治疗原发性中枢神经系统淋巴瘤

获取原文
获取原文并翻译 | 示例

摘要

Objective To explore the therapeutic alternatives and evaluate the related clinical results, of patients with primary central nervous system lymphoma ( PCNSL) treated with gamma knife radiosurgery (GKS). Methods From January 1995 to December 2001, 44 patients suffering from PCNSL, who had undergone stereotactic biopsy or craniotomy, and who had received a confirmed dignosis through pathological examination, were treated with GKS. All cases were followed up for 1 ― 46 months with an average postoperative period of 27 months. The clinical materials, image features, treatment methods and results of follow-up, were retrospectively reviewed. Results The symptoms and signs of the patients were markedly improved within 1 ― 3 weeks after GKS. The Kanofsky performance status was also improved from a preoperative average of 40% to a postoperative one of 90%. Thiry-eight patients (86. 36%) were in complete remission (CR), the other six (13. 63%) were in partial remission (PR). The local control rate reached 100%, and the median survival time was 26. 5 months. The main side effect was brain edema, which can be treated with dexamethasone and mannitol. Conclusion GKS is a safe and effective method in multimodality treatment of PCNSL. A stereotactic biopsy coupled with GKS is the first choice for diagnosis and treatment. Adjuvant chemotherapy or radiotherapy should then be given according to the patient' s condition.
机译:目的探讨伽玛刀放射治疗(GKS)治疗原发性中枢神经系统淋巴瘤(PCNSL)的治疗方案并评估相关的临床结果。方法从1995年1月至2001年12月,对44例PCNSL患者进行了立体定向活检或开颅手术,并经病理检查确诊,对他们进行了GKS治疗。所有病例均获随访1-46个月,平均术后27个月。回顾性分析了临床资料,影像学特征,治疗方法和随访结果。结果GKS术后1〜3周,患者的症状和体征明显改善。 Kanofsky的表现状态也从术前平均40%改善到术后90%。 38例患者(86. 36%)完全缓解(CR),其他6例(13. 63%)部分缓解(PR)。局部控制率达到100%,中位生存时间为26. 5个月。主要的副作用是脑水肿,可以用地塞米松和甘露醇治疗。结论GKS是治疗PCNSL多模态的安全有效方法。立体定向活检结合GKS是诊断和治疗的首选。然后应根据患者的病情进行辅助化疗或放疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号